Drug Profile
Cancer vaccine - Immunotech Laboratories
Alternative Names: IPF-based cancer vaccine - Immunotech Laboratories; Irreversible pepsin fraction-based cancer vaccine - Immunnotech LaboratoriesLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator Immunotech Laboratories
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Cancer in USA
- 01 Jan 2013 Clinical trials in Cancer in USA (unspecified route)